What Is NAD? Medical Abbreviation and Biochemical Meaning

NAD is an abbreviation with two entirely different meanings depending on where you encounter it. In a medical chart or clinical examination note, NAD usually stands for “No Abnormality Detected” or “No Apparent Distress,” a shorthand doctors use to record that a patient looks normal on examination. In biochemistry and the supplement world, NAD stands for nicotinamide adenine dinucleotide, a molecule present in every living cell that is essential for turning food into energy and keeping cellular repair systems running. The biochemical version, typically written as NAD+, has become one of the most talked-about molecules in aging research, and its meaning is worth understanding beyond the abbreviation.

NAD in Medical Records

If you have seen “NAD” scribbled in a doctor’s note or printed on a clinical summary, you almost certainly encountered the medical abbreviation rather than the molecule. Doctors write NAD to indicate that a physical examination revealed nothing out of the ordinary. It might appear next to a body system (“Cardiovascular: NAD”) or as a general assessment (“On examination: NAD”). Some practitioners use it to mean “No Apparent Distress,” describing a patient who is alert, comfortable, and not in visible pain. Either way, it is a quick way for a clinician to document that everything looked fine at that moment. It does not mean every possible test was done or every condition was ruled out. It just means the exam did not flag anything concerning.

The abbreviation is common in British and Commonwealth medical practice and shows up frequently in general-practice notes, emergency department documentation, and specialist letters. In American medical records you are more likely to see phrases like “unremarkable” or “within normal limits,” though NAD appears there too. If your medical record says NAD, that is good news for that particular visit. It has nothing to do with the molecule discussed below.

The Biochemical Molecule

Nicotinamide adenine dinucleotide, or NAD+, is a coenzyme found in every cell in your body. Its most fundamental job is shuttling electrons during the chemical reactions that convert nutrients into usable energy. When NAD+ picks up electrons, it becomes NADH, the reduced form. That back-and-forth between NAD+ and NADH is what keeps your cellular power plants, the mitochondria, generating the energy currency your cells run on. An alteration in the ratio of NAD+ to NADH, or a drop in the total NAD+ pool, can disrupt cellular energy production and has been linked to neurodegenerative disorders, aging, and cancer development.¹

But NAD+ is not just an energy shuttle. It also serves as a raw material that gets consumed by enzymes involved in DNA repair, gene regulation, immune signaling, and cellular stress responses. This dual role, as both a recyclable electron carrier and a consumable substrate, is what makes NAD+ biology so central to health.

How Your Body Makes NAD+

Your cells build NAD+ through multiple routes, and understanding them helps explain why supplement companies market so many different products. The three main pathways are the de novo pathway, the Preiss-Handler pathway, and the salvage pathway.

The de novo pathway starts from the amino acid tryptophan, which you get from protein-rich foods. Through a series of steps called the kynurenine pathway, tryptophan is converted into NAD+. This is the only route that builds NAD+ from scratch rather than recycling existing components.² The de novo pathway matters in certain organs, particularly the kidneys, where reduced tryptophan-to-NAD+ conversion has been connected to acute kidney injury.³

The Preiss-Handler pathway uses nicotinic acid, a form of vitamin B3 also known as niacin, to build NAD+. This is the pathway that historically explained why niacin deficiency causes pellagra, a disease of severe fatigue, skin inflammation, and cognitive decline. When niacin is available in the diet, this pathway works efficiently.

The salvage pathway is arguably the most important for day-to-day maintenance because it recycles nicotinamide, a byproduct released every time an NAD+-consuming enzyme does its job. The rate-limiting step in this recycling process is controlled by an enzyme called NAMPT (nicotinamide phosphoribosyltransferase), which plays a critical role in regulating cell metabolism, aging, and cell survival.⁴ When NAMPT activity drops, the salvage pathway slows down, and NAD+ levels fall. This enzyme’s central position is why so much research focuses on ways to feed the salvage pathway alternative starting materials, which is exactly what NMN and NR supplements aim to do.

What NAD+ Actually Does Beyond Energy

The energy role of NAD+ is well established, but the molecule’s involvement in cellular maintenance is what has generated most of the recent scientific excitement. Two families of enzymes that consume NAD+ as fuel are at the center of this story.

The first family is the sirtuins, a group of seven proteins that remove chemical tags from other proteins to regulate gene activity, DNA repair, mitochondrial health, and inflammation. Sirtuins cannot function without NAD+. They use it as a co-substrate, meaning they break it apart in the course of doing their work. Because sirtuin activity depends on how much NAD+ is available, these enzymes effectively act as metabolic sensors, adjusting cellular maintenance according to the cell’s energy status.⁵ Research in mice has shown that boosting NAD+ levels increases sirtuin activity and can improve mitochondrial function in models of mitochondrial disease.⁶ The range of processes linked to sirtuin activity is broad: cell metabolism, DNA repair, mitochondrial health, and even lifespan in animal models.⁷

The second family is the PARPs (poly-ADP-ribose polymerases), enzymes that detect and help repair damaged DNA. When your DNA breaks, PARP1 rushes to the site and uses NAD+ to build chains of molecular flags that recruit repair machinery. PARP1 is the single largest consumer of NAD+ in the cell nucleus and plays a key role in maintaining genomic integrity.⁸ The catch is that heavy DNA damage can cause PARP1 to burn through NAD+ so aggressively that the cell runs low, starving the sirtuins and other processes that also need it. This tug-of-war between DNA repair demands and overall NAD+ availability is one of the mechanisms researchers believe contributes to aging.

Why NAD+ Drops With Age

One of the most replicated findings in NAD+ research is that levels decline as people get older. The decline has been observed in blood, muscle, and other tissues across both animal and human studies. Multiple mechanisms contribute, but a particularly important one involves an enzyme called CD38. Research has shown that CD38 expression and activity increase with age, and that CD38 is required for the age-related NAD decline and resulting mitochondrial dysfunction, working at least partly through suppression of sirtuin activity.⁹

CD38 is found on immune cells and other tissues, and its main job is breaking down NAD+. As chronic, low-grade inflammation increases with age, CD38 activity ramps up, chewing through more NAD+ than the body can easily replace. Meanwhile, NAMPT activity in the salvage pathway tends to slow down too, creating a double hit. The result is declining NAD+ levels precisely when the repair demands on aging cells are increasing. This decline has been proposed as a contributing factor to cancer, diabetes, cardiovascular disease, and neurodegenerative conditions.¹⁰

NAD+ Precursor Supplements

The discovery of age-related NAD+ decline launched a supplement industry built around NAD+ precursors, the most popular being nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR). Both are forms of vitamin B3 that feed into the salvage pathway, giving cells a shortcut to rebuilding their NAD+ supply. You cannot simply swallow an NAD+ pill and expect it to reach your cells intact; when NAD+ is taken orally or intravenously, it is likely broken down in the gut or liver before cells can use it.¹¹ That is why precursors, which are smaller molecules the body can absorb and then convert to NAD+ inside cells, have become the preferred delivery strategy.

Do these supplements actually raise NAD+ levels in humans? The short answer is yes. A randomized, placebo-controlled trial in healthy middle-aged adults found that blood NAD+ concentrations rose significantly at 30 and 60 days across all NMN dose groups compared to both placebo and baseline, with the highest increases in the 600 mg and 900 mg daily groups.¹² A meta-analysis of randomized controlled trials confirmed the overall effect, finding that NMN supplementation reliably elevated blood NAD+ levels.¹³

Nicotinamide riboside shows similar results. In a double-blind trial of NR supplementation in people with long COVID, NAD+ levels jumped roughly threefold after five weeks of supplementation and remained elevated for the duration of the study.¹⁴ Evidence also suggests that NMN and NR may ultimately work through overlapping mechanisms: gut bacteria appear to convert some NMN into nicotinic acid before it enters the bloodstream, meaning the two supplements may partly converge on the same pathway.¹⁵

Raising NAD+ Doesn’t Mean Raising NAD+ Does What You Want

Here is where the science gets frustrating. Supplements clearly raise NAD+ levels in blood. But raising a blood biomarker is not the same as improving health outcomes. Most human trials of NMN and NR have been short, typically lasting a few weeks to a few months, and have focused on safety and biomarker changes rather than on whether people actually feel better, live longer, or avoid disease. Reviews of the existing clinical evidence consistently flag that there are many unknowns around dosage, timing, bioavailability, tissue-specific delivery, and long-term safety.¹⁶

That said, supplementation with NAD+ precursors has been found to be safe and tolerable in the studies conducted so far, and it does increase NAD+ and related metabolites in multiple tissues.¹⁷ The gap between “raises NAD+” and “slows aging” is the gap where the hype lives. Animal studies, particularly in mice, have shown striking benefits from NAD+ boosting, including improved muscle function, better metabolic health, and even extended lifespan in some models. Translating those results to humans has been slower and less dramatic, which is typical of aging research in general. It does not mean the approach is wrong, but it means anyone spending serious money on these supplements is betting on incomplete evidence.

Exercise as an NAD+ Strategy

If raising NAD+ is the goal, there is a free intervention with strong supporting evidence: exercise. A study of middle-aged, overweight, previously untrained adults found that a resistance-training program more than doubled muscle NAD+ levels (an increase of about 127%), while also raising NADH, NAMPT protein levels, and overall sirtuin activity in muscle tissue.¹⁸ The magnitude of that increase is striking, particularly because it came from regular weight training rather than a pharmaceutical intervention. Aerobic exercise also appears to support NAD+ metabolism, though the specific measurements vary by study and tissue type.

The exercise findings are worth remembering when evaluating supplement claims. A 127% increase in muscle NAD+ from lifting weights is a larger effect than most supplement trials report for blood NAD+, though comparing across tissues and measurement methods is tricky. At minimum, exercise activates many of the same downstream pathways, boosting sirtuin activity and mitochondrial health, that NAD+ supplements are trying to target.

NAD+ in Cancer Research

One area of NAD+ biology that gets less public attention but matters enormously is cancer. Cancer cells proliferate rapidly and have high energy demands, making them heavily dependent on NAD+. The same salvage pathway enzyme that maintains healthy cells, NAMPT, is also what keeps many tumors fueled. NAMPT mediates the rate-limiting step of the salvage pathway, maintaining the cellular energy supply and providing a necessary substrate for functions essential to rapidly dividing cancer cells.¹⁹

This creates an uncomfortable tension in the NAD+ field. On one hand, boosting NAD+ may help healthy cells maintain their repair systems and resist age-related decline. On the other hand, flooding the body with extra NAD+ precursors could theoretically feed existing cancers or precancerous cells that depend on high NAD+ turnover. NAMPT inhibitors are actually being studied as anti-cancer drugs, working on the principle that starving a tumor of NAD+ can kill it. Whether long-term NAD+ supplementation meaningfully increases cancer risk in humans is unknown. No clinical trials have shown that it does, but no long-term studies have been powered to rule it out either. This uncertainty is one of the key reasons researchers urge caution about treating NAD+ boosting as a casual wellness strategy.¹⁶

How NAD+ Is Measured

When you see claims about NAD+ levels rising or falling, those numbers come from laboratory measurements that are more complicated than a standard blood test. The most precise method uses high-performance liquid chromatography (HPLC), which separates NAD+ from dozens of chemically similar molecules in a tissue or blood sample. Researchers have confirmed that this technique can isolate NAD+ with greater than 99% purity from mammalian cell extracts, distinguishing it from related metabolites that would otherwise inflate the reading.²⁰ The measurements are then compared to a standard curve and adjusted for tissue weight or cell count.

This matters because some consumer testing services now offer “NAD+ level” tests, and the quality of measurement varies widely. A blood NAD+ level taken at one lab using one method is not directly comparable to a muscle NAD+ level from a research study using HPLC. If you are considering testing your own NAD+ levels to guide supplementation, keep in mind that no consensus reference ranges exist for healthy adults, and a single snapshot does not tell you much about what is happening inside your tissues. The clinical utility of measuring NAD+ in a doctor’s office is, for now, essentially nil. It remains a research tool rather than a diagnostic one.